Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2017-02-23 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLOERMEL (56800), Morbihan
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE COLINEAUX-LE GREZAUSE : revenue, balance sheet and financial ratios
PHARMACIE COLINEAUX-LE GREZAUSE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLOERMEL (56800),
this company of category PME
shows in 2025 a net income positive of 60 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE COLINEAUX-LE GREZAUSE (SIREN 828021659)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
59 636 €
120 386 €
122 726 €
155 913 €
165 339 €
147 795 €
183 089 €
35 512 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE COLINEAUX-LE GREZAUSE generates positive net income of 60 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 36 k€ -> 60 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
59 636 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 52%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
52.255%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.329%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1228.516
490.913
304.662
188.468
127.417
97.126
67.81
52.255
Financial autonomy
6.491
14.812
22.125
30.97
39.373
46.526
54.792
56.329
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
52.262025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-7 pts over 3 years
In 2025, the debt ratio of PHARMACIE COLINEAUX-LE GR... (52.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
56.33%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE COLINEAUX-LE GR... (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 143.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
172.682
220.942
263.142
241.755
240.399
281.546
229.875
143.925
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
143.932025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-44 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE COLINEAUX-LE GR... (143.93) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE COLINEAUX-LE GREZAUSE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE COLINEAUX-LE GREZAUSE is estimated at
947 324 €
(range 642 859€ - 1 486 483€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
642k€947k€1486k€
947 324 €Range: 642 859€ - 1 486 483€
NAF 5 année 2025
Valuation method used
Net Income Multiple
59 636 €
×
15.9x
=947 325 €
Range: 642 859€ - 1 486 483€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE COLINEAUX-LE GREZAUSE with other companies in the same sector:
Frequently asked questions about PHARMACIE COLINEAUX-LE GREZAUSE
What is the revenue of PHARMACIE COLINEAUX-LE GREZAUSE ?
The revenue of PHARMACIE COLINEAUX-LE GREZAUSE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE COLINEAUX-LE GREZAUSE profitable?
Yes, PHARMACIE COLINEAUX-LE GREZAUSE generated a net profit of 60 k€ in 2025.
Where is the headquarters of PHARMACIE COLINEAUX-LE GREZAUSE ?
The headquarters of PHARMACIE COLINEAUX-LE GREZAUSE is located in PLOERMEL (56800), in the department Morbihan.
Where to find the tax return of PHARMACIE COLINEAUX-LE GREZAUSE ?
The tax return of PHARMACIE COLINEAUX-LE GREZAUSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE COLINEAUX-LE GREZAUSE operate?
PHARMACIE COLINEAUX-LE GREZAUSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart